Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RPH-104 in Colchicine-Resistant FMF
NCT05092776Phase 2Active, not recruiting
- Sponsor
- R-Pharm
- Start
- Apr 2021
- Primary completion
- Jan 2025
- Modality
- Fc-Fusion Proteins
- Countries
- 4
01
Overview
A Phase 2 trial of goflikicept in Familial Mediterranean fever (FMF), sponsored by R-Pharm. Started Apr 2021; status: active, not recruiting.
02
Drugs
goflikicept
03
Conditions
Familial Mediterranean fever (FMF)
Beyond the preview
Go deeper on NCT05092776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05092776.